Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.59 is 18% above its 5-year average of 1.35, near the high end of its 5-year range (0.70–1.79).
As of the fiscal period ended Tuesday, June 30, 2026. 2.20% above its 12-month average of 1.56.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.59.
CURRENT RATIO
1.59
CURRENT RATIO AVG TTM
1.56
CURRENT RATIO AVG 3Y
1.37
CURRENT RATIO AVG 5Y
1.35
CURRENT RATIO AVG 10Y
2.78
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+2.20%
CURRENT VS 3Y AVG
+16.45%
CURRENT VS 5Y AVG
+18.10%
CURRENT VS 10Y AVG
-42.83%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-57.71%
vs the sector median at left
Journey Medical Corporation
Market Cap
$169.53M
Current Ratio
1.59
TTM Avg
1.56
3Y Avg
1.37
5Y Avg
1.35
Market Cap
$171.13M
Current Ratio
12.82
TTM Avg
9.83
3Y Avg
6.43
5Y Avg
5.45
Market Cap
$172.42M
Current Ratio
3.52
TTM Avg
3.66
3Y Avg
3.27
5Y Avg
3.06
Market Cap
$173.76M
Current Ratio
3.49
TTM Avg
3.52
3Y Avg
4.49
5Y Avg
5.44
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Journey Medical Corporation (DERM) | $169.53M | 1.59 | 1.56 | 1.37 | 1.35 |
| MediWound Ltd. (MDWD)vs › | $168.92M | 2.32 | 2.15 | 3.17 | 2.88 |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | 1.25 | 2.29 | 3.57 | 4.16 |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | 12.82 | 9.83 | 6.43 | 5.45 |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | 3.52 | 3.66 | 3.27 | 3.06 |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 5.58 | 2.96 | 5.18 | 6.05 |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | 3.49 | 3.52 | 4.49 | 5.44 |
| Nkarta, Inc. (NKTX)vs › | $165.27M | 7.98 | 13.57 | 13.59 | 18.24 |
| Yarrow Bioscience Inc (YARW)vs › | $174.27M | 15.26 | 8.44 | 8.43 | 6.86 |
| Quanterix Corporation (QTRX)vs › | $162.04M | 3.40 | 5.75 | 8.37 | 8.52 |
Current Ratio
1.59
Quick Ratio
1.41
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.59 |
| 2026-03-31 | 1.72 |
| 2025-12-31 | 1.79 |
| 2025-09-30 | 1.42 |
| 2025-06-30 | 1.27 |
| 2025-03-31 | 1.34 |
| 2024-12-31 | 1.37 |
| 2024-09-30 | 1.38 |
| 2024-06-30 | 1.36 |
| 2024-03-31 | 1.21 |
| 2023-12-31 | 1.35 |
| 2023-09-30 | 0.92 |
| 2023-06-30 | 0.70 |
| 2023-03-31 | 0.79 |
| 2022-12-31 | 1.16 |
| 2022-09-30 | 1.31 |
| 2022-06-30 | 1.40 |
| 2022-03-31 | 1.48 |
| 2021-12-31 | 1.64 |
| 2021-09-30 | 1.12 |
| 2021-06-30 | 1.20 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 1.26 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-09-30 | 7.04 |
| 2019-06-30 | 8.42 |
| 2019-03-31 | 7.13 |
| 2018-12-31 | 8.70 |
| 2018-09-30 | 5.29 |
| 2018-06-30 | 4.78 |
| 2018-03-31 | 5.17 |
| 2017-12-31 | 5.28 |
| 2017-09-30 | 4.68 |
| 2017-06-30 | 24.43 |
| 2017-03-31 | 20.33 |
| 2016-12-31 | 8.12 |
| 2016-09-30 | 9.53 |
| 2016-06-30 | 11.95 |
| 2016-03-31 | 7.25 |
| 2015-12-31 | 8.39 |
| 2015-09-30 | 11.61 |
| 2015-06-30 | 9.48 |
| 2015-03-31 | 10.38 |
| 2014-12-31 | 8.87 |
